Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vitiligo management update.

W Westerhof1

  • 1Netherlands Institute for Pigmentary Disorders, Department of Dermatology, University of Amsterdam, The Netherlands.

Skin Therapy Letter
|July 13, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-oxidant defence mechanism in vitiliginous skin increases with skin type.

Journal of the European Academy of Dermatology and Venereology : JEADV·2011
Same author

A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2009
Same author

The spectral stability of several sunscreening agents on stratum corneum sheets.

International journal of cosmetic science·2009
Same author

Ultrastructural findings in progressive macular hypomelanosis indicate decreased melanin production.

Journal of the European Academy of Dermatology and Venereology : JEADV·2008
Same author

Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?

Experimental dermatology·2008
Same author

Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.

Clinical and experimental dermatology·2007
Same journal

Exosomes in Dermatology.

Skin therapy letter·2026
Same journal

Zasocitinib: New Frontier in Tyrosine Kinase 2 Inhibition.

Skin therapy letter·2026
Same journal

Erratum to: Deuruxolitinib for Alopecia Areata.

Skin therapy letter·2026
Same journal

Advances in the Management of Hyperhidrosis.

Skin therapy letter·2026
Same journal

Topical Ruxolitinib for the Treatment of Hidradenitis Suppurativa.

Skin therapy letter·2026
Same journal

Icotrokinra: A Promising Oral IL-23 Receptor Inhibitor for Moderate-to-Severe Plaque Psoriasis.

Skin therapy letter·2026
See all related articles

Vitiligo is a skin disorder causing white patches due to pigment cell loss, affecting 1% of the population. Treatments include UV therapy and cell transplantation, with sunscreens aiding management.

Area of Science:

  • Dermatology
  • Immunology
  • Genetics

Background:

  • Vitiligo is an acquired skin disorder characterized by depigmentation, leading to white patches.
  • Reduced melanin increases sun sensitivity and can cause cosmetic disfigurement and psychological distress.
  • Affecting approximately 1% of the global population, vitiligo typically manifests between ages 10-30, equally in males and females.

Purpose of the Study:

  • To summarize the current understanding of vitiligo.
  • To outline emerging treatment modalities for vitiligo.
  • To provide guidance on managing vitiligo symptoms and psychosocial impact.

Main Methods:

  • Review of existing literature on vitiligo.
  • Description of current and novel therapeutic approaches.

Related Experiment Videos

  • Discussion of supportive care and coping strategies.

    • Main Results:

    • Vitiligo etiology remains unknown, with potential factors including genetics, autoimmunity, and melanocyte vulnerability.
    • Treatment options encompass corticosteroid and UVA therapy, narrow-band UVB (311 nm) irradiation, and autologous pigment cell transplantation.
    • Depigmentation agents can be used for widespread vitiligo, while sunscreens and camouflage offer symptomatic relief.

    Conclusions:

    • Vitiligo is a complex skin condition with significant psychosocial implications.
    • A range of treatments are available, from UV therapies to cell transplantation.
    • Comprehensive management includes medical treatment, symptomatic relief, and patient support.